Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

Delayed Quote. Delayed  - 08/26 05:35:12 pm
0.78 EUR   --.--%
07/19 NEOVACS : and Stellar Biotechnologies Announce Launch of Neostell, J..
06/23 NEOVACS : EUR 8 million capital increase successfully completed
05/30 NEOVACS : to Present at Bio International Convention 2016
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
0.79(c) 0.79(c) 0.77(c) 0.78(c) 0.78(c) Last
200 625 150 228 269 316 106 371 28 876 Volume
-1.25% 0.00% -2.53% +1.30% 0.00% Change
More quotes
Financials (€)
Sales 2016 -
EBIT 2016 -11,2 M
Net income 2016 -9,56 M
Debt 2016 2,89 M
Yield 2016 -
Sales 2017 875 M
EBIT 2017 3,42 M
Net income 2017 -9,82 M
Finance 2017 14,5 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 0
EV / Sales2017 0,02x
Capitalization 33,5 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Surperformance© ratings of Neovacs
Trading Rating : - Investor Rating :
More Ratings
Latest news on NEOVACS
07/19 NEOVACS : and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture..
07/19 DGAP-NEWS : Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joi..
06/23 NEOVACS : EUR 8 million capital increase successfully completed
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 DGAP-NEWS : Neovacs to Present at Bio International Convention 2016
05/17 DGAP-NEWS : Neovacs to attend ChinaBio(R) Event May 18 & 19, 2016
05/17 NEOVACS : to attend ChinaBio® Event May 18 & 19, 2016
05/12 NEOVACS : and Stellar Biotechnologies sign joint venture agreement to create Neo..
05/12 DGAP-NEWS : Neovacs and Stellar Biotechnologies sign a joint venture agreement t..
More news
Sector news : Biotechnology & Medical Research - NEC
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 1,70 €
Spread / Average Target 118%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Miguel Sieler Chief Executive Officer & Director
Jean-Jacques Bertrand Chairman
Baptiste Pourtout Head-Finance
Géraldine Grouard-Vogel Chief Scientific Officer
Thérèse Croughs Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NEOVACS-26.40%38
INCYTE CORPORATION-25.27%15 236
CELLTRION, INC.--.--%11 367
LONZA GROUP AG14.78%10 130
QUINTILES TRANSNATIONA..10.24%8 968
ALKERMES PLC-43.94%6 744
More Results